Facebook
Twitter
LinkedIn
Forward
2nd Annual Bradley Z. Naifeh Amyloidosis Conference - Medical Professional Conference - March 1, 2024
In-Person and Virtual attendance options are available.
Houston Methodist J.C. Walter Conference Series
Presented by: Bradley Z. Naifeh Amyloidosis Clinical Research and Treatment Program at Houston Methodist J.C. Walter Jr. Transplant Center
Amyloidosis is an underrecognized condition because it has historically been misconceived to be a rare disease and presents in a myriad of clinical situations in a subtle manner. Recent advances in therapeutics have made it imperative that this condition is recognized and categorized appropriately in a timely manner so that individuals can get access to appropriate care. Due to a systemic nature of amyloid, various subspecialities are on the fore front of battling this disease. The goal of the Conference is to create a faculty panel from various disciplines to engage in the mission to promote awareness and educate attendees on Amyloidosis in a comprehensive manner.
FEES
| REGISTRATION TYPE | FEE |
|---|---|
| Physician (HM, MPAQ, ACO PCP) | Complimentary |
| Physician (Private physician located within the Greater Houston Area)* | $205 |
| Physician (Private physician located within the Greater Houston Area; NO CE) Click here to register! | Complimentary |
| Physician (Private physician located outside the Greater Houston Area) | Complimentary |
| Allied Health Care Professionals / All Others | Complimentary |
| Resident / Fellow / Student (No CME) | Complimentary |
* In compliance with HM’s policy on Physician Non-Monetary Compensation regarding “Stark Law,” private physicians who reside and/or practice medicine within the Greater Houston Area are required to pay the full Fair Market Value registration fee.
Target Audience
Cardiologists, hematologists, neurologists, nephrologists, pulmonologists, hepatologists, nurse practitioners, nurses, social workers, transplant coordinators, and trainees in these subspecialities
Learning Objectives
Upon completion of this course, the participant should be able to:
- Discuss the two major kinds (AL and TTR) of amyloidosis and appropriate diagnosis and categorization of these kinds.
- Identify how to investigate the various organ involvement in Amyloidosis.
- Discuss the current approved therapies for the two major kinds of amyloidosis (AL and TTR).
- Describe the potential future therapies for both TTR and AL amyloidosis.
| Bradley Z. Naifeh 2nd Annual Amyloidosis Conference Medical Professionals | ||
| AGENDA │ Friday, March 1, 2024 | ||
| Time | Topics | Speaker |
| 8:00 AM | Welcome | R. Mark Ghobrial, MD, PhD, FACS, FRCS(Ed) |
| 8:05 AM | Overview of Amyloidosis mission at Houston Methodist | A. Osama Gaber, MD, FACS |
| 8:10 AM | Introduction of the Bradley Z. Naifeh Amyloidosis Program | Arvind Bhimaraj, MD, MPH, FACC, FHFSA Barry Trachtenberg, MD, FACC Janardhana R. Gorthi, MD |
| 8:15 AM | A message from the Naifeh Family | Megan Fleischfresser Naifeh |
| 8:25 AM | Conference Introduction by Course Directors | Arvind Bhimaraj, MD, MPH, FACC, FHFSA Barry Trachtenberg, MD, FACC Janardhana R. Gorthi, MD |
| PLENARY SESSION I AMYLOIDOSIS: EARLY DIAGNOSIS AND RAISING AWARENESS MODERATORS: Arvind Bhimaraj, MD, Dipan Shah, MD and Barry Trachtenberg, MD PANELIST PARTICIPANT: Mouaz Al-Mallah, MD | ||
| 8:30 AM | Liver: The Culprit or the Bystander in TTR Amyloidosis | David Victor, MD |
| 8:45 AM | Amyloidosis: Types and Pathophysiology | Barry Trachtenberg, MD, FACC |
| 9:00 AM | Amyloidosis diagnosis: Imaging perspective | Sharmila Dorbala, MD, MPH |
| 9:25 AM | Why does Amyloidosis get missed? Clinical clues to not miss it | Doug Horstmanshof, MD, FACC |
| 9:40 AM | Q&A and Discussion | |
| 9:50 AM | Panel Discussion: Amyloidosis awareness - Partnership with patients and organizations (ASB, ARC, ASG, ICOSNA) Panel Discussion: Strategies for Future Collaboration to Support our Patients | ASB: Deb Boedicker, CFA ARC: David Gibson, PhD, CMPP ASG: John Mathison ICOSNA: Benjamin Lavine |
| 10:30 AM | BREAK | |
| PLENARY SESSION II TREATMENT OPTIONS MODERATORS: Barry Trachtenberg, MD, Lawrence Rice, MD and Arvind Bhimaraj, MD PANELIST PARTICIPANT: Siddhartha Ganguly, MD | ||
| 10:45 AM | Treatment options for TTR Amyloid: Current and future | Ronald M. Witteles, MD |
| 11:10 AM | Treatment options for AL amyloidosis | Angela Dispenzieri, MD |
| 11:35 AM | Neurological burden of disease and advancements in treatment options for Amyloidosis | Sheetal Shroff, MD |
| 11:50 AM | Q&A and Discussion | |
| 12:00 PM | LUNCH | |
| PLENARY SESSION III AMYLOIDOSIS: A MULTISYSTEM DISEASE MODERATORS: Arvind Bhimaraj, MD, Janardhana Gorthi, MD, Barry Tractenberg, MD, and Rammurti Kamble, MD | ||
| 1:30 PM | Orthopedic involvement in Amyloidosis: An early investment for diagnosis | Shari R. Liberman, MD |
| 1:55 PM | Cardiac Risk in AL Amyloidosis Patients Amidst Advances in the Current Era | Jean Bernard Durand, MD |
| 2:20 PM | Kidney disease due to Amyloidosis | Juan Gonzalez, MD |
| 2:45 PM | Q&A and Discussion | |
| 2:55 PM | Debate #1: BMT is a critical treatment option for AL: PRO Debate #2: BMT is a critical treatment option for AL: CON | Angela Dispenzieri, MD Ronald M. Witteles, MD |
| 3:15 PM | REBUTTAL | |
| 3:25 PM | Q&A and Discussion | |
| 3:35 PM | BREAK | |
| 3:50 PM | Case #1: TTR Case #2: AL | Javier Amione, MD Zimu Gong, MD and Hanh Mai, MD |
| 4:10 PM | Q&A and Discussion | |
| 4:20 PM | Concluding Remarks | |
| 4:25 PM | Adjourn | |
In-Person attendance will be held in the Houston Methodist Research Institute (6670 Bertner Avenue, Houston, Texas 77030).
Virtual information will be provided to registered learners.
Available Credit
- 6.00 AMA PRA Category 1 Credit™
Houston Methodist is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Houston Methodist designates this Live activity for a maximum of 6.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- 6.00 Attendance
- 6.00 Nursing Contact Hours
Houston Methodist is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.
Houston Methodist will award 6.00 Nursing Continuing Professional Development contact hours for this activity. Participants must attend the activity in its entirety and complete the continuing education evaluation.
- 5.75 Transplant CoordinatorsThe American Board for Transplant Certification (ABTC) has assigned the following Continuing Education Points for Transplant Certification (CEPTCs) to the following Houston Methodist Transplant Center educational program: 2nd Annual Bradley Z. Naifeh Amyloidosis Conference - Medical Professional Conference - March 1, 2024 | Thu, 11/30/2023 - 8:00am | 5.75 Category 1 CEPTCs
Interested in exhibiting? Contact us for more information.
Price
REGISTRATION INSTRUCTIONS
- STEP 1 - Choose the activity format you would like to attend (LIVE or LIVESTREAM) by selecting the checkbox next to the activity and clicking the "Enroll" button.
- STEP 2 - Once enrolled, click the link of the activity format for which you enrolled (the Status should say "In progress") and then click the "Take Course" button to begin the activity.
FEES
| REGISTRATION TYPE | FEE |
|---|---|
| Physician (HM, MPAQ, ACO PCP) | Complimentary |
| Physician (Private physician located within the Greater Houston Area)* | $205 |
| Physician (Private physician located within the Greater Houston Area; NO CE) Click here to register! | Complimentary |
| Physician (Private physician located outside the Greater Houston Area) | Complimentary |
| Allied Health Care Professionals / All Others | Complimentary |
| Resident / Fellow / Student (No CME) | Complimentary |
* In compliance with HM’s policy on Physician Non-Monetary Compensation regarding “Stark Law,” private physicians who reside and/or practice medicine within the Greater Houston Area are required to pay the full Fair Market Value registration fee.